British stocks rise on fresh stimulus hopes, Chinese data

*FTSE 100 up 0.9%, FTSE 250 adds 0.4%. The FTSE 100 rose 0.9%, climbing for the second straight session, with life insurers and travel stocks leading gains, while the mid-cap index advanced 0.4%. In company news, drugmaker GSK rose 1% and was among the biggest boosts to the FTSE 100 after announcing a clinical trial of a COVID-19 vaccine candidate along with French…

(For a live blog on European stocks, type LIVE/ in an Eikon

news window)

* FTSE 100 up 0.9%, FTSE 250 adds 0.4%

Sept 3 (Reuters) – London shares rose on Thursday asinvestors bet on new stimulus measures to drive a fasterpost-pandemic economic rebound, while a sustained recovery inChina’s services sector also lifted sentiment.

The FTSE 100 rose 0.9%, climbing for the secondstraight session, with life insurers and travelstocks leading gains, while the mid-cap indexadvanced 0.4%

Bank of England Deputy Governor Dave Ramsden on Wednesdayhinted of more liquidity as he warned of higher risks toBritain’s economy from the coronavirus crisis than spelt out bythe central bank last month.

In company news, drugmaker GSK rose 1% and was amongthe biggest boosts to the FTSE 100 after announcing a clinicaltrial of a COVID-19 vaccine candidate along with Frenchdrugmaker Sanofi.(Reporting by Shashank Nayar in Bengaluru; Editing bySubhranshu Sahu)

ANA NEWS WIRE Disclaimer:
The African News Agency (ANA) is a news wire service and therefore subscribes to the highest standards of journalism as it relates to accuracy, fairness and impartiality.
ANA strives to provide accurate, well sourced and reliable information across Text, Images and Video. Where errors do appear, ANA will seek to correct these timeously and transparently.
The ANA platform also contains news and information from third party sources. ANA has sought to procure reliable content from trusted news sources but cannot be held responsible for the accuracy and opinions provided by such sources on the ANA platform or linked sites.
The content provided for on the ANA News Wire platform, both through the ANA news operation and via its third party sources, are for the sole use of authorised subscribers and partners. Unauthorised access to and usage of ANA content will be subject to legal steps. ANA reserves its rights in this regard.
ANA makes every effort to ensure that the website is up and running smoothly at all times, however ANA does not take responsibility for, and will not be held liable for times when the website is temporarily unavailable due to technical issues that are beyond our control.